(Reuters) - The U.S. Food and Drug Administration on Tuesday rejected Prevention Bio Inc.'s approval of the experimental diabetes drug teplizumab, citing insufficient data,...
"Overcoming Ambiguous Loss," the first of a series of four virtual workshops sponsored by the Nebraska Caregiver Coalition, will take place via Zoom Thursday,...